These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 27537678)

  • 21. Structural Modifications of the Quinolin-4-yloxy Core to Obtain New
    Cannalire R; Mangiaterra G; Felicetti T; Astolfi A; Cedraro N; Massari S; Manfroni G; Tabarrini O; Vaiasicca S; Barreca ML; Cecchetti V; Biavasco F; Sabatini S
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32987835
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Capsaicin, a novel inhibitor of the NorA efflux pump, reduces the intracellular invasion of Staphylococcus aureus.
    Kalia NP; Mahajan P; Mehra R; Nargotra A; Sharma JP; Koul S; Khan IA
    J Antimicrob Chemother; 2012 Oct; 67(10):2401-8. PubMed ID: 22807321
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of hydroxyamines derived from lapachol and norlachol against Staphylococcus aureus strains carrying the NorA efflux pump.
    Figueredo FG; Ramos ITL; Paz JA; Silva TMS; Câmara CA; de Morais Oliveira-Tintino CD; Tintino SR; de Farias PAM; Menezes IRA; Coutinho HDM; Fonteles MMF
    Infect Genet Evol; 2020 Oct; 84():104370. PubMed ID: 32445918
    [TBL] [Abstract][Full Text] [Related]  

  • 24. First identification of boronic species as novel potential inhibitors of the Staphylococcus aureus NorA efflux pump.
    Fontaine F; Hequet A; Voisin-Chiret AS; Bouillon A; Lesnard A; Cresteil T; Jolivalt C; Rault S
    J Med Chem; 2014 Mar; 57(6):2536-48. PubMed ID: 24499135
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the tannic acid inhibitory effect against the NorA efflux pump of Staphylococcus aureus.
    Tintino SR; Oliveira-Tintino CD; Campina FF; Silva RL; Costa Mdo S; Menezes IR; Calixto-Júnior JT; Siqueira-Junior JP; Coutinho HD; Leal-Balbino TC; Balbino VQ
    Microb Pathog; 2016 Aug; 97():9-13. PubMed ID: 27057677
    [TBL] [Abstract][Full Text] [Related]  

  • 26. An Update on
    Monteiro KLC; de Aquino TM; Mendonça Junior FJB
    Curr Top Med Chem; 2020; 20(24):2168-2185. PubMed ID: 32621719
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues.
    Felicetti T; Cannalire R; Burali MS; Massari S; Manfroni G; Barreca ML; Tabarrini O; Schindler BD; Sabatini S; Kaatz GW; Cecchetti V
    ChemMedChem; 2017 Aug; 12(16):1293-1302. PubMed ID: 28598572
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of omeprazole analogues and evaluation of these as potential inhibitors of the multidrug efflux pump NorA of Staphylococcus aureus.
    Vidaillac C; Guillon J; Arpin C; Forfar-Bares I; Ba BB; Grellet J; Moreau S; Caignard DH; Jarry C; Quentin C
    Antimicrob Agents Chemother; 2007 Mar; 51(3):831-8. PubMed ID: 17101679
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump.
    Sabatini S; Gosetto F; Manfroni G; Tabarrini O; Kaatz GW; Patel D; Cecchetti V
    J Med Chem; 2011 Aug; 54(16):5722-36. PubMed ID: 21751791
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inhibition of the essential oil from Chenopodium ambrosioides L. and α-terpinene on the NorA efflux-pump of Staphylococcus aureus.
    de Morais Oliveira-Tintino CD; Tintino SR; Limaverde PW; Figueredo FG; Campina FF; da Cunha FAB; da Costa RHS; Pereira PS; Lima LF; de Matos YMLS; Coutinho HDM; Siqueira-Júnior JP; Balbino VQ; da Silva TG
    Food Chem; 2018 Oct; 262():72-77. PubMed ID: 29751924
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dithiazole thione derivative as competitive NorA efflux pump inhibitor to curtail multi drug resistant clinical isolate of MRSA in a zebrafish infection model.
    Lowrence RC; Raman T; Makala HV; Ulaganathan V; Subramaniapillai SG; Kuppuswamy AA; Mani A; Chittoor Neelakantan S; Nagarajan S
    Appl Microbiol Biotechnol; 2016 Nov; 100(21):9265-9281. PubMed ID: 27531512
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effects of NorA inhibition on the activities of levofloxacin, ciprofloxacin and norfloxacin against two genetically related strains of Staphylococcus aureus in an in-vitro infection model.
    Aeschlimann JR; Kaatz GW; Rybak MJ
    J Antimicrob Chemother; 1999 Sep; 44(3):343-9. PubMed ID: 10511401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synthesis, biological evaluation and computational studies of acrylohydrazide derivatives as potential Staphylococcus aureus NorA efflux pump inhibitors.
    Kumar G; Goutami Godavari A; Tambat R; Kumar S; Nandanwar H; Elizabeth Sobhia M; Jachak SM
    Bioorg Chem; 2020 Nov; 104():104225. PubMed ID: 32992278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Novel inhibitory activity of the Staphylococcus aureus NorA efflux pump by a kaempferol rhamnoside isolated from Persea lingue Nees.
    Holler JG; Christensen SB; Slotved HC; Rasmussen HB; Gúzman A; Olsen CE; Petersen B; Mølgaard P
    J Antimicrob Chemother; 2012 May; 67(5):1138-44. PubMed ID: 22311936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of expression of NorA efflux pump in ciprofloxacin resistant Staphylococcus aureus against hexahydroquinoline derivative by real-time PCR.
    Pourmand MR; Yousefi M; Salami SA; Amini M
    Acta Med Iran; 2014; 52(6):424-9. PubMed ID: 25130148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Indirubin potentiates ciprofloxacin activity in the NorA efflux pump of Staphylococcus aureus.
    Ponnusamy K; Ramasamy M; Savarimuthu I; Paulraj MG
    Scand J Infect Dis; 2010 Jul; 42(6-7):500-5. PubMed ID: 20380543
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ferulic acid derivative inhibits NorA efflux and in combination with ciprofloxacin curtails growth of MRSA in vitro and in vivo.
    Sundaramoorthy NS; Mitra K; Ganesh JS; Makala H; Lotha R; Bhanuvalli SR; Ulaganathan V; Tiru V; Sivasubramanian A; Nagarajan S
    Microb Pathog; 2018 Nov; 124():54-62. PubMed ID: 30118803
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Potentiating activity of Norfloxacin by synthetic chalcones against NorA overproducing Staphylococcus aureus.
    Alves Borges Leal AL; Teixeira da Silva P; Nunes da Rocha M; Marinho EM; Marinho ES; Marinho MM; Bandeira PN; Sampaio Nogueira CE; Barreto HM; Rodrigues Teixeira AM; Silva Dos Santos H
    Microb Pathog; 2021 Jun; 155():104894. PubMed ID: 33894291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. C2 Arylated Benzo[b]thiophene Derivatives as Staphylococcus aureus NorA Efflux Pump Inhibitors.
    Liger F; Bouhours P; Ganem-Elbaz C; Jolivalt C; Pellet-Rostaing S; Popowycz F; Paris JM; Lemaire M
    ChemMedChem; 2016 Feb; 11(3):320-30. PubMed ID: 26732895
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The phenolic diterpene totarol inhibits multidrug efflux pump activity in Staphylococcus aureus.
    Smith EC; Kaatz GW; Seo SM; Wareham N; Williamson EM; Gibbons S
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4480-3. PubMed ID: 17664318
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.